Posaconazole Oral Suspension 40 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Oral Suspension
Available Strengths: 40 mg/mL
Reference Brands: Noxafil(US & EU)
Category: Anti-fungal
Posaconazole oral suspension inhibits fungal cytochrome P450 14α-demethylase, disrupting ergosterol synthesis and fungal cell membrane integrity. It offers broad-spectrum antifungal activity, improved absorption, and versatility for prophylaxis and treatment of invasive fungal infections. Benefits include effective coverage, convenient dosing, and high bioavailability for managing severe fungal diseases.
Product Description:
Posaconazole oral suspension is approved in the EU and US for prophylaxis and treatment of invasive fungal infections. In the EU, MSD’s Noxafil suspension is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and quality. In the US, FDA approval is based on comprehensive clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and continual safety monitoring. For expert support with dossiers, regulatory submissions, and compliance, visit PharmaTradz. We help ensure smooth market entry and adherence to European and American standards, enabling effective management of fungal infections with posaconazole oral suspension.
Posaconazole Oral Suspension — third party manufacturing & bulk supply
Posaconazole Oral Suspension 40 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Posaconazole Oral Suspension listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Posaconazole Oral Suspension →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Posaconazole is used to prevent and treat serious fungal infections in high-risk patients, especially those with weakened immune systems such as individuals with hematologic cancers or transplant recipients. It is effective against invasive aspergillosis, mucormycosis, and resistant Candida infections, and is often used when other antifungals are not tolerated or have failed.
Posaconazole contains the active triazole antifungal compound posaconazole. The formulation uses specific pharmaceutical excipients designed to enhance absorption in the digestive system and ensure stable systemic exposure.
The main trade name is Noxafil, widely used in the USA, EU, UK, and other international regions.
Noxafil is manufactured by Merck & Co. (MSD). Several GMP-certified global pharmaceutical manufacturers also produce generic posaconazole for different markets.
The generic name is posaconazole.
The primary brand name is Noxafil.
Posaconazole is manufactured in Merck’s regulated facilities in the USA and Europe, along with additional GMP-approved manufacturers that supply generic posaconazole for worldwide distribution.
Related Products
Tioconazole
Strength:
6.5%, 300 mg, 1%
Form: Vaginal Capsule / Vaginal Cream/ topical cream
Reference Brands: Vagistat-1 (USA), Trosyd (EU/LATAM)
View DetailsTerconazole
Strength:
0.4%, 0.8%, 80 mg, 120 mg
Form: Cream / Vaginal suppository
Reference Brands: Terazol (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers